you are here:

Fresenius Kabi Oncology Ltd.

BSE: 532545 | NSE: FKONCO | Series: NA | ISIN: INE575G01010 | SECTOR: Pharmaceuticals

BSE Live

Jan 02, 15:50
132.45 0.00 (0.00%)
Volume
No Data Available
91,518
  • Prev. Close

    132.45

  • Open Price

    132.00

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    132.45 (20430)

Fresenius Kabi Oncology is not traded on BSE in the last 30 days

NSE Live

Nov 17, 15:16
1348.00 0.00 (0.00%)
Volume
No Data Available
1,345
  • Prev. Close

    1348.00

  • Open Price

    1343.88

  • Bid Price (Qty.)

    1348.00 (4)

  • Offer Price (Qty.)

    1351.46 (1)

Fresenius Kabi Oncology is not traded on NSE in the last 30 days

Financials

2020 2019 2018 2017 2016
Nine Months Results of Fresenius Kabi Oncology (in Rs. Cr.) Dec '13 Dec '12 Dec '11 Dec '10 Dec '09  
Net Sales/Income from operations 207.78 425.70 366.40 322.50 305.88  
Other Operating Income 99.90 77.36 36.13 -- --  
Total Income From Operations 307.68 503.06 402.53 322.50 305.88  
EXPENDITURE  
Consumption of Raw Materials 124.52 140.19 140.42 100.88 111.46  
Purchase of Traded Goods 4.94 2.77 2.40 1.84 --  
Increase/Decrease in Stocks -32.24 3.50 28.27 5.35 -26.93  
Power & Fuel -- -- -- -- --  
Employees Cost 55.87 52.92 43.11 41.39 32.53  
Depreciation 22.78 19.26 17.91 11.61 9.62  
Excise Duty -- -- -- -- --  
Admin. And Selling Expenses -- -- -- -- --  
R & D Expenses 84.96 85.77 48.38 30.46 25.04  
Provisions And Contingencies -- -- -- -- --  
Exp. Capitalised -- -- -- -- --  
Other Expenses 126.75 86.27 84.66 56.87 75.98  
P/L Before Other Inc. , Int., Excpt. Items & Tax -79.91 112.39 37.37 74.09 78.18  
Other Income 7.06 0.98 1.24 2.64 5.31  
P/L Before Int., Excpt. Items & Tax -72.85 113.37 38.61 76.73 83.50  
Interest 12.58 -0.54 8.90 13.20 15.87  
P/L Before Exceptional Items & Tax -85.42 113.91 29.70 63.53 67.63  
Exceptional Items -- -- -- -- --  
P/L Before Tax -85.42 113.91 29.70 63.53 67.63  
Tax 5.75 25.56 7.20 19.93 10.06  
P/L After Tax from Ordinary Activities -91.18 88.35 22.51 43.60 57.57  
Prior Year Adjustments -- -- -- -- --  
Extra Ordinary Items -12.44 -- 26.76 2.68 4.59  
Net Profit/(Loss) For the Period -103.62 88.35 49.27 46.28 62.16  
Equity Share Capital 15.82 15.82 15.82 15.82 15.82  
Reserves Excluding Revaluation Reserves -- -- -- -- --  
Equity Dividend Rate (%) -- -- -- -- --  
EPS Before Extra Ordinary  
Basic EPS -5.76 5.58 1.42 2.76 --  
Diluted EPS -5.76 5.58 1.42 2.76 --  
EPS After Extra Ordinary  
Basic EPS. -6.55 5.58 3.11 2.92 --  
Diluted EPS. -6.55 5.58 3.11 2.92 --  
Public Share Holding  
No Of Shares (Crores) 1.32 3.01 1.58 1.58 1.58  
Share Holding (%) 8.31 19.00 10.00 10.00 10.00  
Promoters and Promoter Group Shareholding  
a) Pledged/Encumbered  
- Number of shares (Crores) -- -- -- -- --  
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- -- --  
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- -- --  
b) Non-encumbered  
- Number of shares (Crores) 14.51 12.82 14.24 14.24 --  
- Per. of shares (as a % of the total sh. of prom. and promoter group) 100.00 100.00 100.00 100.00 --  
- Per. of shares (as a % of the total Share Cap. of the company) 91.69 81.00 90.00 90.00 --  
Source : Dion Global Solutions Limited